Skip to content

Atomoxetine

Atomoxetine (Strattera) is a non-stimulant medicine listed for attention deficit hyperactivity disorder, or ADHD, in children and adults. This catalogue contains the Axepta and Strattera tablet formulations.

Medicines containing Atomoxetine

Axepta

Attention Deficit Hyperactivity Disorder

10mg · 18mg · 25mg · 40mg

Atomoxetine tablets for attention deficit hyperactivity disorder. It is a non-stimulant, which makes it an option for those who cannot tolerate stimulant medicines.

From$0.89/ tabletView

Strattera

Attention Deficit Hyperactivity Disorder

10mg · 18mg · 25mg · 40mg

Atomoxetine tablets for attention deficit hyperactivity disorder. It is a non-stimulant option that raises norepinephrine levels in the brain.

From$0.79/ capsuleView

Key points

  • A norepinephrine reuptake inhibitor is a type of non-stimulant medicine used for ADHD.
  • A boxed warning says children and adolescents starting atomoxetine need close monitoring for suicidal thoughts, behaviour changes or worsening symptoms.
  • Atomoxetine is not approved for major depressive disorder.

Why the boxed warning is included

The warning comes from a pooled analysis of 12 short-term studies involving more than 2,200 children and adolescents with ADHD. Suicidal ideation occurred in five of 1,357 people taking atomoxetine, or 0.4%, and none of 851 placebo participants; no suicides occurred.

Further reading